...
首页> 外文期刊>Therapeutic advances in gastroenterology. >Endoscopic resection techniques for squamous premalignant lesions and early carcinoma of the esophagus: ER-Cap, MBM, and ESD, how do we choose? A multicenter experience
【24h】

Endoscopic resection techniques for squamous premalignant lesions and early carcinoma of the esophagus: ER-Cap, MBM, and ESD, how do we choose? A multicenter experience

机译:内镜切除技术用于鳞状畸变病变和食管早期癌:ER-CAP,MBM和ESD,我们如何选择?多中心的经验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Endoscopic resection cap technique (ER-Cap), multiband mucosectomy (MBM), and endoscopic submucosal dissection (ESD) have been widely applied in the treatment of esophageal squamous neoplasia and cancer. However, little is known with regards to the comparison of these methods. This study aimed to compare the feasibility, safety, effectiveness, and costs of these three techniques. Methods: A retrospective analysis of patients with squamous premalignant or early malignant lesions of the esophagus undergoing ER-Cap, MBM, or ESD from January 2009 to December 2015 in one of the centers in China was performed. The procedural data and follow-up data for all patients were recorded. Results: A total of 672 patients with 733 lesions were included; 148 lesions (133 patients) were treated with ER-Cap, 427 lesions (388 patients) with MBM, and 158 lesions (151 patients) with ESD. The mean age was 61.59?years and the male-to-female ratio was 2.78:1. The operation time was significantly shorter for ER-Cap (29.26?±?16.73?mins, p? Conclusions: ER-Cap, MBM, and ESD are all minimally invasive, safe, and effective methods for treating early esophageal squamous cell carcinoma. MBM could be considered as a good alternative when performed by a less-experienced endoscopist in high-incidence areas with limited resources.
机译:背景:内镜切除帽技术(ER-Cap),多频带粘膜切除术(MBM)和内窥镜粘膜切除术(ESD)被广泛应用于食管鳞状瘤形成和癌症的治疗。然而,对于这些方法的比较,知之甚少。本研究旨在比较这三种技术的可行性,安全性,有效性和成本。方法:在中国2009年1月至2015年1月,在中国的一个抗鳞状或早期恶性病变患者的回顾性分析,MBM或ESD在中国的一个中心。记录所有患者的程序数据和后续数据。结果:共有672例733例病变患者; 148例病变(133名患者)用ER-Cap,427例病变(388名患者)和MBM和158例病变(151名患者)进行治疗。平均年龄为61.59?年龄,男性对女性比例为2.78:1。 ER-Cap的操作时间明显缩短(29.26?±16.73?mins,P?结论:ER-Cap,MBM和ESD都是针对治疗早期食管鳞状细胞癌的全部侵入性,安全和有效的方法。MBM可以被认为是在具有有限资源有限的高发型区域的少经验率区域进行的良好替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号